Literature DB >> 16634598

Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid.

Louise K Charkoudian1, Katherine J Franz.   

Abstract

The Fe(III)-coordination chemistry of neuromelanin building-block compounds, 5,6-dihydroxyindole (DHI), 5,6-dihydroxyindole-2-carboxylic acid (DHICA), and 5,6-dihydroxy-N-methyl-indole (Me-DHI), and the neurotransmitter dopamine were explored in aqueous solution by anaerobic pH-dependent spectrophotometric titrations. The Fe(III)-binding constants and pH-dependent speciation parallel those of catechol in that mono, bis, and tris FeLx species are present at concentrations dependent on the pH. The bis FeL2 dihydroxyindole species are favorable for L = DHI and DHICA under neutral to mildly acidic conditions. DHI and DHICA are stronger Fe(III) chelates than catechol, dopamine, and Me-DHI at pH values from 3 to 10. Oxidation studies reveal that iron accelerates the air oxidation of DHI and DHICA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634598     DOI: 10.1021/ic060014r

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  33 in total

1.  The Pneumococcal Iron Uptake Protein A (PiuA) Specifically Recognizes Tetradentate FeIIIbis- and Mono-Catechol Complexes.

Authors:  Yifan Zhang; Katherine A Edmonds; Daniel J Raines; Brennan A Murphy; Hongwei Wu; Chuchu Guo; Elizabeth M Nolan; Michael S VanNieuwenhze; Anne-K Duhme-Klair; David P Giedroc
Journal:  J Mol Biol       Date:  2020-08-11       Impact factor: 5.469

Review 2.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

3.  Fast and versatile fabrication of PMMA microchip electrophoretic devices by laser engraving.

Authors:  Ellen Flávia Moreira Gabriel; Wendell Karlos Tomazelli Coltro; Carlos D Garcia
Journal:  Electrophoresis       Date:  2014-08       Impact factor: 3.535

4.  Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease.

Authors:  Dianlu Jiang; Shuyun Shi; Lin Zhang; Lin Liu; Bingrong Ding; Bingqing Zhao; Gargey Yagnik; Feimeng Zhou
Journal:  ACS Chem Neurosci       Date:  2013-07-17       Impact factor: 4.418

5.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

6.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

7.  Reactivity of catecholamine-driven Fenton reaction and its relationships with iron(III) speciation.

Authors:  Victoria Melin; Adolfo Henríquez; Juanita Freer; David Contreras
Journal:  Redox Rep       Date:  2014-12-12       Impact factor: 4.412

8.  PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition.

Authors:  Quinn P Peterson; David R Goode; Diana C West; Kara N Ramsey; Joy J Y Lee; Paul J Hergenrother
Journal:  J Mol Biol       Date:  2009-03-10       Impact factor: 5.469

9.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

10.  Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.

Authors:  Vivek Lawana; Se Young Um; Rachel M Foguth; Jason R Cannon
Journal:  Neurotoxicology       Date:  2020-10-13       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.